Pacific Biosciences Of California: Pay

Pacific Biosciences Of California paid its 3 named executives $10.2M in total in FY2025 (Dec). CEO Christian O. Henry was paid $4.3M of that.

Pay$100 in the stock at the end of FY20 → $7
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Christian O. HenryPresident and Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Jim R. GibsonChief Financial Officer
FY2025 (Dec)
1 year
Mark Van OeneChief Operating Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 10 peers with pay on file was $6.3M. The CEO of Pacific Biosciences Of California was paid $4.3M, 32% below the median.

  1. 1Twist Bioscience
  2. 2Adaptive Biotechnologies
  3. 3Veracyte
  4. 4Castle Biosciences
  5. 510x Genomics
  6. 6AbCellera Biologics
  7. 7Fulgent Genetics
  8. 8Repligen
  9. 9Myriad Genetics
  10. 10Cytek Biosciences
  11. 11Pacific Biosciences Of California
  12. 12AzentaNot disclosed
  13. 13Ginkgo Bioworks HoldingsNot disclosed
  14. 14Guardant HealthNot disclosed
  15. 15NeogenomicsNot disclosed
  16. 16QuanterixNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.